⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer

Official Title: A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer

Study ID: NCT01097018

Study Description

Brief Summary: The trial will compare the overall survival of perifosine plus capecitabine to placebo plus capecitabine in patients with refractory advanced colorectal cancer.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

, Alhambra, California, United States

, Bakersfield, California, United States

, La Verne, California, United States

, Long Beach, California, United States

, Los Angeles, California, United States

, Northridge, California, United States

, Redondo Beach, California, United States

, Santa Barbara, California, United States

, Santa Maria, California, United States

, Denver, Colorado, United States

, Grand Junction, Colorado, United States

Yale University School of Medicine, New Haven, Connecticut, United States

, Stamford, Connecticut, United States

, Waterbury, Connecticut, United States

, Fort Myers, Florida, United States

, Hollywood, Florida, United States

, Pembroke Pines, Florida, United States

, Athens, Georgia, United States

, Atlanta, Georgia, United States

, Lawrenceville, Georgia, United States

, Marietta, Georgia, United States

, Roswell, Georgia, United States

, Harvey, Illinois, United States

, Park Ridge, Illinois, United States

, South Bend, Indiana, United States

, Terre Haute, Indiana, United States

, Baltimore, Maryland, United States

, Bethesda, Maryland, United States

, Lansing, Michigan, United States

, Jackson, Mississippi, United States

, Tupelo, Mississippi, United States

, St. Louis, Missouri, United States

, Lincoln, Nebraska, United States

, Henderson, Nevada, United States

, Las Vegas, Nevada, United States

, Morristown, New Jersey, United States

, Albuquerque, New Mexico, United States

, Albuquerque, New Mexico, United States

, Armonk, New York, United States

, Great Neck, New York, United States

, New Hyde Park, New York, United States

, New York City, New York, United States

, Charlotte, North Carolina, United States

, Bismark, North Dakota, United States

, Fargo, North Dakota, United States

, Cincinnati, Ohio, United States

, Columbus, Ohio, United States

, Oklahoma City, Oklahoma, United States

, Columbia, South Carolina, United States

, Chattanooga, Tennessee, United States

, Memphis, Tennessee, United States

TN Oncology, Nashville, Tennessee, United States

, Abilene, Texas, United States

, Austin, Texas, United States

, Beaumont, Texas, United States

, Dallas, Texas, United States

, Dallas, Texas, United States

, Dallas, Texas, United States

, Fort Worth, Texas, United States

, Houston, Texas, United States

, Midland, Texas, United States

, Tyler, Texas, United States

, Richmond, Virginia, United States

, Seattle, Washington, United States

, Spokane, Washington, United States

Contact Details

Name: Johanna Bendell, MD

Affiliation: SCRI Development Innovations, LLC

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: